| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 19/06/2024 | 00:38 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RENB | Renovaro Inc |
| 14/06/2024 | 15:06 | GlobeNewswire Inc. | Renovaro, Inc. Announces $10 million in Equity Committed | NASDAQ:RENB | Renovaro Inc |
| 11/06/2024 | 17:29 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:RENB | Renovaro Inc |
| 24/05/2024 | 22:33 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RENB | Renovaro Inc |
| 24/05/2024 | 15:20 | GlobeNewswire Inc. | Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy | NASDAQ:RENB | Renovaro Inc |
| 18/05/2024 | 03:37 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:RENB | Renovaro Inc |
| 30/04/2024 | 17:00 | GlobeNewswire Inc. | Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics | NASDAQ:RENB | Renovaro Inc |
| 24/04/2024 | 15:00 | GlobeNewswire Inc. | RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership | NASDAQ:RENB | Renovaro Inc |
| 18/04/2024 | 14:45 | GlobeNewswire Inc. | Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Ca | NASDAQ:RENB | Renovaro Inc |
| 23/02/2024 | 23:01 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:RENB | Renovaro Inc |
| 23/02/2024 | 22:04 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | NASDAQ:RENB | Renovaro Inc |
| 22/02/2024 | 22:17 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:RENB | Renovaro Inc |
| 15/02/2024 | 15:25 | GlobeNewswire Inc. | Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace | NASDAQ:RENB | Renovaro Inc |
| 14/02/2024 | 16:01 | GlobeNewswire Inc. | Statement of Renovaro Inc | NASDAQ:RENB | Renovaro Inc |
| 13/02/2024 | 15:31 | GlobeNewswire Inc. | AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine | NASDAQ:RENB | Renovaro Inc |
| 25/01/2024 | 18:45 | GlobeNewswire Inc. | Renovaro Biosciences Announces Results of Special Meeting of Shareholders | NASDAQ:RENB | Renovaro Inc |
| 16/01/2024 | 14:00 | GlobeNewswire Inc. | Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD | NASDAQ:RENB | Renovaro Inc |
| 11/10/2023 | 15:25 | GlobeNewswire Inc. | Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors | NASDAQ:RENB | Renovaro Inc |
| 10/10/2023 | 14:00 | GlobeNewswire Inc. | Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors | NASDAQ:RENB | Renovaro Inc |
| 06/10/2023 | 22:30 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:RENB | Renovaro Inc |
| 04/10/2023 | 22:20 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:RENB | Renovaro Inc |
| 02/10/2023 | 18:05 | GlobeNewswire Inc. | Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD | NASDAQ:RENB | Renovaro Inc |
| 02/10/2023 | 15:28 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:RENB | Renovaro Inc |
| 02/10/2023 | 15:25 | GlobeNewswire Inc. | AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine | NASDAQ:RENB | Renovaro Inc |
| 02/10/2023 | 13:30 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:RENB | Renovaro Inc |
| 30/09/2023 | 09:32 | Business Wire | GEDi Cube e Renovaro Biosciences siglano un accordo definitivo per realizzare una business combination | NASDAQ:RENB | Renovaro Inc |
| 30/09/2023 | 09:32 | Business Wire | GEDi Cube und Renovaro Biosciences unterzeichnen endgültige Fusionsvereinbarung | NASDAQ:RENB | Renovaro Inc |
| 29/09/2023 | 23:00 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:RENB | Renovaro Inc |
| 29/09/2023 | 19:36 | Business Wire | GEDi Cube et Renovaro Biosciences signent un accord définitif de fusion | NASDAQ:RENB | Renovaro Inc |
| 29/09/2023 | 15:15 | Business Wire | GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine | NASDAQ:RENB | Renovaro Inc |